Recalls / Active ingredient / Phenytoin Sodium
Phenytoin Sodium
5 FDA drug recalls involving the active ingredient “Phenytoin Sodium”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-10-27 | Class II | Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC B | Amneal Pharmaceuticals of New York, LLC |
| 2023-05-30 | Class II | Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Phar | Amneal Pharmaceuticals of New York, LLC |
| 2022-11-14 | Class III | Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42 | Acella Pharmaceuticals, LLC |
| 2022-11-14 | Class III | Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02, packaged in 10 x 2 mL vials per carton, NDC 421 | Acella Pharmaceuticals, LLC |
| 2013-08-17 | Class II | Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal PHARMACEUTICALS label, NDC 651 | Amneal Pharmaceuticals of New York, LLC. |